Trump FDA chief is leaving after angering pharma CEOs, vaping lobbyists and anti-abortion groups

Dr. Marty Makary, the head of the Food and Drug Administration (FDA), has resigned after a challenging year marked by criticism from various groups, including health industry executives and political allies of President Trump. Makary, known for his opposition to COVID-19 health measures, struggled with the FDA’s internal issues, including staff resignations and controversies over political influence on scientific decisions. His tenure was further complicated by balancing demands to reduce regulatory barriers while ensuring the safety of vaccines and drugs. The agency faced low morale and dysfunction, with Makary’s deputy, Dr. Vinay Prasad, also leaving amid conflicts. Makary’s resignation comes amid criticism from anti-abortion and vaping groups, highlighting the political pressures on the FDA. Kyle Diamantas, with ties to Donald Trump Jr., is expected to become the acting commissioner. QUESTION: How might political influences on scientific agencies like the FDA impact public trust in health and safety regulations?